Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
![]() |
![]() |
|||||||
GSE256252 |
Macrophage responses to zinc-limited and zinc-replete Mycobacterium tuberculosis H37Rv
|
15 |
|
Sladjana Prisic | Jan 17, 2025 | |||
GSE285754 |
Transcriptomic Profile of Neuroinflammation in Alzheimer’s Mouse Brain Treated With and Without Extracellular Vesicles
|
18 | Robert Paul Krattli Jr | Jan 17, 2025 | ||||
GSE285096 |
Comparison of transcriptomic data obtained from stimulated and unstimulated samples for the stratification of patients with a compromised immune system [REALISM cohort]
|
114 | Marion Debombourg | Jan 15, 2025 | ||||
GSE285098 |
Comparison of transcriptomic data obtained from stimulated and unstimulated samples for the stratification of patients with a compromised immune system (in the context of sepsis and allogeneic hematopoietic stem cell transplantation)
|
256 | Marion Debombourg | Jan 15, 2025 | ||||
GSE285892 |
Gene expression analysis of frozen skin from B6 mouse models of Cutaneous Lupus Erythematosus and Primary Cicatricial Alopecia
|
24 | Jillian M Richmond | Jan 06, 2025 | ||||
GSE196502 |
The impact of reduced PLCG2 expression on microglial biology and disease pathology in a murine model of Alzheimer’s disease
|
48 | Andy P Tsai | Jan 01, 2025 | ||||
GSE273225 |
The effect of rewarming ischemia on tissue transcriptome signatures: a clinical observational study in lung transplantation
|
118 |
|
Johan Van Weyenbergh | Jan 01, 2025 | |||
GSE283218 |
JAKaL: Phase Ib study of itacitinib, a selective JAK1 inhibitor, for the management of advanced stage hepatocellular cancer after failure of first line therapy.
|
6 | Rohini Sharma | Jan 01, 2025 | ||||
GSE133730 |
Pathway-Associated Gene Expression in Mouse GI Tissues Under Western Diet and Fetal Antibiotic Exposure.
|
119 | Jeffrey Robinson | Dec 31, 2024 | ||||
GSE213609 |
Proteogenomic profiling of thymic and pulmonary neuroendocrine neoplasia.
|
53 | Hanibal Bohnenberger | Dec 31, 2024 | ||||
GSE214904 |
Gene expression in High-Grade Serous Ovarian Cancer (HGSOC) cells
|
8 |
|
Chia-Ho Cheng | Dec 31, 2024 | |||
GSE220443 |
Multi-omic profiling of digital papillary adenocarcinomas reveals alterations in matrix remodeling and metabolic genes
|
19 | Varshini Vasudevaraja | Dec 31, 2024 | ||||
GSE285291 |
Intestinal Mucosal Mitochondrial Oxidative Phosphorylation worsens with Cirrhosis Progression and is ameliorated with FMT
|
53 | Grayson Welch Way | Dec 26, 2024 | ||||
GSE285299 |
Gene expression associated with endocrine therapy resistance in estrogen receptor-positive breast cancer
|
80 | Yate-Ching Yuan | Dec 25, 2024 | ||||
GSE251930 |
Targeting WNT Signaling for Improved Glioma Immunotherapy [IL13R?2-targeted CAR T cells]
|
8 | Yate-Ching Yuan | Dec 20, 2024 | ||||
GSE266162 |
Urolithin A and Nicotinamide Riboside differentially regulate innate immune defenses and metabolism.
|
18 |
|
Supriyo De | Dec 19, 2024 | |||
GSE280043 |
miRNA Nanostring Data on a Silk Scaffold model following CCI injury
|
72 | Simone Grant | Dec 11, 2024 | ||||
GSE281698 |
Gene expression analysis of different motor neuron genotypes and their response to biological exposure and AAV treatment
|
23 | Andreia Duarte | Dec 01, 2024 | ||||
GSE281714 |
Gene expression analysis of different motor neuron genotypes and their response to biological exposure and AAV treatment [neuropathology]
|
23 | Andreia Duarte | Dec 01, 2024 | ||||
GSE253388 |
Nanostring protein expression of immune cell recruitment and BBB breakdown following Aβ immunotherapy
|
7 | Xavier Taylor | Nov 29, 2024 |